Xiangyi Kong

5.5k total citations · 2 hit papers
202 papers, 3.5k citations indexed

About

Xiangyi Kong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiangyi Kong has authored 202 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 45 papers in Molecular Biology and 38 papers in Cancer Research. Recurrent topics in Xiangyi Kong's work include Cancer Immunotherapy and Biomarkers (24 papers), Glioma Diagnosis and Treatment (15 papers) and Breast Cancer Treatment Studies (14 papers). Xiangyi Kong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (24 papers), Glioma Diagnosis and Treatment (15 papers) and Breast Cancer Treatment Studies (14 papers). Xiangyi Kong collaborates with scholars based in China, United States and Australia. Xiangyi Kong's co-authors include Yi Fang, Zhongzhao Wang, Jun Gao, Xiangyu Wang, Kuo Chu Hwang, Yi Fang, Yihang Qi, Yanguo Kong, Renzhi Wang and Ran Cheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Xiangyi Kong

185 papers receiving 3.5k citations

Hit Papers

Inhibition of APOC1 promo... 2022 2026 2023 2024 2022 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
    2022 194 citations Hanyuan Liu, Xiangyi Kong et al. profile →
  2. Advances of medical nanorobots for future cancer treatments
    2023 105 citations Xiangyi Kong, Kuo Chu Hwang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangyi Kong China 32 1.0k 783 692 597 397 202 3.5k
Maria Filomena Botelho Portugal 34 1.3k 1.3× 905 1.2× 582 0.8× 663 1.1× 677 1.7× 277 4.6k
Gang Zhao China 33 1.5k 1.4× 656 0.8× 631 0.9× 640 1.1× 514 1.3× 155 3.4k
Wen Xu China 32 1.8k 1.8× 1.1k 1.4× 747 1.1× 672 1.1× 476 1.2× 157 4.2k
Jianfeng Li China 34 1.7k 1.7× 961 1.2× 680 1.0× 381 0.6× 324 0.8× 162 4.7k
Zheng Li China 32 1.3k 1.3× 1.2k 1.6× 700 1.0× 843 1.4× 437 1.1× 232 3.7k
Yi Cui China 39 1.5k 1.4× 575 0.7× 834 1.2× 550 0.9× 284 0.7× 147 4.4k
Ying Jing China 41 2.1k 2.0× 1.1k 1.3× 769 1.1× 452 0.8× 400 1.0× 167 5.1k
Bo Li China 36 1.9k 1.8× 989 1.3× 888 1.3× 501 0.8× 890 2.2× 238 4.3k
Bo Yang China 32 1.1k 1.1× 861 1.1× 531 0.8× 483 0.8× 331 0.8× 218 3.3k

Countries citing papers authored by Xiangyi Kong

Since Specialization
Citations

This map shows the geographic impact of Xiangyi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyi Kong more than expected).

Fields of papers citing papers by Xiangyi Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyi Kong. The network helps show where Xiangyi Kong may publish in the future.

Co-authorship network of co-authors of Xiangyi Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyi Kong. A scholar is included among the top collaborators of Xiangyi Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyi Kong. Xiangyi Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Xiangyi, et al.. (2025). Recent Advances in X-ray Absorption Spectroscopy for Battery Applications. The Journal of Physical Chemistry C. 129(8). 3993–4009. 3 indexed citations
2.
Kong, Xiangyi, Xiangyu Wang, Wenxiang Zhang, et al.. (2025). Combating cancer immunotherapy resistance: a nano‐medicine perspective. Cancer Communications. 45(7). 813–840. 3 indexed citations
3.
Fang, Lijuan, et al.. (2024). Unlocking the potential of extracellular vesicle circRNAs in breast cancer: From molecular mechanisms to therapeutic horizons. Biomedicine & Pharmacotherapy. 180. 117480–117480. 1 indexed citations
4.
Wang, Xiangyu, et al.. (2024). Investigation on the Changes of Perioperative Psychological State of Young Patients With Early Breast Cancer. Psycho-Oncology. 33(12). e70027–e70027. 1 indexed citations
5.
Pei, Shengbin, Qiang Liu, Xiangyi Kong, et al.. (2024). Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer. Frontiers in Immunology. 15. 1489444–1489444. 3 indexed citations
6.
Liu, Gang, et al.. (2023). Clinical Features and Prognoses of Patients With Breast Cancer Who Underwent Surgery. JAMA Network Open. 6(8). e2331078–e2331078. 8 indexed citations
7.
Kong, Xiangyi, et al.. (2023). Combined Gadolinium and Boron Neutron Capture Therapies for Eradication of Head-and-Neck Tumor Using Gd10B6 Nanoparticles under MRI/CT Image Guidance. SHILAP Revista de lepidopterología. 3(8). 2192–2205. 13 indexed citations
8.
Kong, Xiangyi, Yu Cui, Songfeng Chen, et al.. (2023). Transcranial direct‐current stimulation confers neuroprotection by regulating isoleucine‐dependent signalling after rat cerebral ischemia–reperfusion injury. European Journal of Neuroscience. 58(5). 3330–3346. 2 indexed citations
9.
Kong, Xiangyi, Li Chen, Zhaohui Su, et al.. (2023). Toxicities associated with immune checkpoint inhibitors: a systematic study. International Journal of Surgery. 109(6). 1753–1768. 9 indexed citations
10.
Li, Huixian, Peiqing Ma, Wenbin Li, et al.. (2023). A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway. BMC Cancer. 23(1). 1163–1163. 1 indexed citations
11.
Sun, Guangshun, Hanyuan Liu, Jie Zhao, et al.. (2022). Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy. Journal for ImmunoTherapy of Cancer. 10(12). e005655–e005655. 29 indexed citations
12.
Kong, Xiangyi, et al.. (2021). Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment. Journal of Cellular and Molecular Medicine. 25(22). 10327–10348. 24 indexed citations
13.
Liu, Qiang, Zhongzhao Wang, Xiangyi Kong, et al.. (2020). A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer. DNA and Cell Biology. 39(4). 671–682. 8 indexed citations
14.
15.
Liu, Qiang, Xiangyu Wang, Xiangyi Kong, et al.. (2020). Prognostic Alternative mRNA Splicing Signature and a Novel Biomarker in Triple-Negative Breast Cancer. DNA and Cell Biology. 39(6). 1051–1063. 11 indexed citations
16.
17.
Kong, Xiangyi, Shun Gong, Lijuan Su, Chen Li, & Yanguo Kong. (2017). Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas. Journal of Cellular and Molecular Medicine. 22(1). 123–130. 6 indexed citations
18.
19.
Kong, Xiangyi, Jian Guan, Yi Yang, et al.. (2015). A meta-analysis: Do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures?. Clinical Neurology and Neurosurgery. 134. 98–103. 32 indexed citations
20.
Kong, Xiangyi, et al.. (2006). Investigation of the Fe~(3+) reduction properties of Shewanella decolorationis S12. 33(3). 98–103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Filomena Botelho Breakdown of academic impact, for papers by Gang Zhao Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Jianfeng Li Breakdown of academic impact, for papers by Zheng Li Breakdown of academic impact, for papers by Yi Cui Breakdown of academic impact, for papers by Ying Jing Breakdown of academic impact, for papers by Bo Li Breakdown of academic impact, for papers by Bo Yang
Rankless by CCL
2026